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ABSTRACT
Endovascular methods of aneurysm treatment, as an alternative to neurosurgical clipping, have proved a welcome opportunity 
to treat patients with unruptured aneurysms or those disqualified from neurosurgical intervention. This paper presents our own 
experience of endovascular treatment of cerebral aneurysms in 107 patients. It includes clinical and technical data from the 
perioperative period and a 12-month radiological follow-up of 78 patients. 
Method. Our retrospective evaluation covered patients with intracranial aneurysms treated endovascularly. The following were 
analysed: age, sex, neurological symptoms, and familial burden of intracranial aneurysm. Multivariate analysis was performed 
to determine independent factors of recanalisation of the cerebral aneurysm 12 months after embolisation. 
Results. The data of 107 patients at a mean age of 61 years [57.09 ± 14.27] treated with embolisation was analysed. The indica-
tion for intervention in 16 patients was subarachnoid haemorrhage; in the remaining 91 cases, aneurysms were revealed during 
diagnostic procedures for different symptoms or during imaging examinations. The intracranial segment of the internal carotid 
artery and the anterior communicating artery were the most common locations for aneurysms. After embolisation, subarach-
noid haemorrhage occurred in one patient, ischaemic stroke in two patients, and one patient died because of acute circulatory 
insufficiency. The functional status of 94 patients on the day of discharge from the department (on days 4-21) was very good. 78 
patients completed a 12-month follow-up period. In 11 of those, a follow-up MR angiography revealed recanalisation 12 months 
after the intervention. Except for one patient reporting vertigo, aneurysm recanalisation procedures were asymptomatic. The 
only independent risk factor for recanalisation was the size of aneurysm > 10 mm; OR 3.0; CI [1.15–7.83] p = 0.0255.
Conclusions. Embolisation of cerebral aneurysms is a safe method with few perioperative complications, and most of these are 
mild and transient.The size of the aneurysm during qualification for embolisation is a risk factor for recanalisation in the subse-
quent 12 months. Recanalisation of embolised cerebral aneurysms concerns less than 20% of patients in a one-year follow-up 
and is most often asymptomatic.
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Background
Intracranial aneurysms, assessed on the basis of post mor-
tem examinations, are estimated to affect 1–5% of the adult 
population [1]. They are reported three times more frequently 
in women than in men [2]. Most cerebral aneurysms do not 
rupture. Improved access to neuroimaging examinations has 
enabled physicians to find more intracranial vascular abnor-
malities prior to the appearance of neurological symptoms. 
Endovascular methods of aneurysm treatment, as an alternative 
to neurosurgical clipping, have proved a welcome opportunity 
for patients with unruptured aneurysms and have helped those 
disqualified from neurosurgical intervention. Compared to sur-
gical clipping of aneurysms, endovascular therapy is substan-
tially less invasive [3]. The risk of aneurysm rupture depends on 
the patient’s clinical profile (i.e. age, location, familial burden of 
aneurysms) and the morphological features of that aneurysm 
(size and shape) [3]. Before deciding about the indication for 
a specific treatment and before the choice of method, the risk 
of natural course (i.e. will the aneurysm rupture if no interven-
tion is performed) is compared against the risk related to the 
particular neurosurgical or endovascular procedure.
There are these days many different techniques used in 
endovascular treatment of cerebral aneurysms, e.g. simple 
coiling, balloon remodelling, stent remodelling, 2-stent 
remodelling in various configurations, flow diversion, and 
intrasaccular flow disruption, as well as combinations of the 
abovementioned methods. 
The choice of a specific treatment technique depends on 
a number of factors, i.e.: the morphology of the aneurysm and 
in particular the width of the aneurysm neck, the preference 
of the operator, the availability of equipment in the laboratory, 
and the anatomy of the arteries feeding the aneurysm [4]. 
Aneurysm recanalisation after endovascular treatment affects 
up to one third of patients, usually within the 12 months fol-
lowing intervention. The risk of recanalisation depends on the 
parameters related to the morphology of the aneurysm and 
the technical aspects of the procedure.
This study looks at the effectiveness and safety of embolisa-
tion of ruptured and unruptured cerebral artery aneurysms.
Method
This paper presents our own experience with endovas-
cular treatment of mostly unruptured cerebral aneurysms in 
107 patients exhibiting clinical and technical data from the 
perioperative period and at least a 12-month radiological 
follow-up of 78 patients (72.89% of the 107).
Retrospective evaluation involved 108 patients who, be-
tween January 2017 and December 2019, were hospitalised 
in the Neurology Department of the Upper-Silesian Medical 
Centre of the Silesian Medical University in Katowice, Poland 
for embolisation of ruptured or unruptured intracranial aneu-
rysms with the use of coils and/or stents. Preliminary diagnosis 
of an aneurysm was established on the basis of head computed 
tomography (CT) or magnetic resonance (MR) angiography 
(CTA, MRA).
The following data was analysed: the age and the sex of the 
patient qualified for embolisation, their neurological symp-
toms, any other diseases, and any family history of intracranial 
aneurysm. Moreover, the parameters related to aneurysm, i.e. 
size, location, rupture and individual history, were analysed for 
the presence of other aneurysms and previous endovascular 
procedures. For the description of parametric data, the mean 
and standard deviation, median, minimum and maximum 
values of a given variable in the study group were calculated. 
Multivariate analysis was performed to determine independent 
factors of recanalisation (based on MR angiography) of the 
cerebral aneurysm 12 months after embolisation. The follow-
ing parameters were analysed: age, sex, arterial hypertension, 
diabetes, dyslipidemia and the size of the aneurysm (i.e. 
< 10 mm, 10–24 mm, or > 24 mm).
Description of cerebral aneurysm embolisation
All patients undergoing diagnostic procedures had a digital 
subtraction angiography (DSA) performed using X-ray (Sie-
mens Axiom Artis dTa) as per the defined protocols. The other 
part of the examination involved the use of a DSA worksta-
tion for further image analysis. Aneurysms were analysed at 
the DSA station based on the imaging results. The following 
features were assessed:
 — location;
 — aneurysm sac dimensions – the longest dimension of 
length, height, and width;
 — aneurysm neck dimension – the diameter measured in 
two extreme dimensions;
 — sac-to-neck ratio – the longest sac dimension and the 
longest neck dimension were used for calculations; these 
were divided into three groups: ratio < 1.2; between 1.2 and 
1.5; and >1.5 [5];
 — aneurysm size – the aneurysms were divided by size: 
small aneurysm < 10 mm in diameter; large aneurysm 
10–24 mm; or giant aneurysm > 25 mm [6, 7]. The assess-
ment of the aneurysm sac is presented in Figure 1. 
Depending on the sac-to-neck ratio, the aneurysms were 
treated using the following techniques:
a) simple coiling;
b) balloon remodelling;
c) stent remodelling using:
• a single stent,
• or two stents in Y, X or T configurations;
d) flow diversion.
The coils were implanted into the aneurysm sac using 
a micro-catheter and they were detached while using fluoro-
scopic viewing. The coils were introduced into the aneurysm 
sac until the aneurysm was filled up and no more coils could 
be inserted, or until no further inflow of the contrast agent 
into the aneurysm sac could be seen in angiography.
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Figure 1A. Left internal carotid artery aneurysm in the ophthalmic 
segment (C6) — the sac dimension (length and height)
Figure 1B. Left internal carotid artery aneurysm in the ophthalmic 
segment (C6) — the sac dimension (width)
Stent embolisation was mainly applied in patients with 
wide-neck aneurysms. The most commonly used was the hy-
brid stent (Atlas by Stryker) and the second most commonly 
used was  the braided stent (Leo, Leo Baby by Balt). Flow 
diverters (Silk by Balt) were used in small quantities and only 
if no other endovascular technique was suitable for the given 
aneurysm. A stent was implanted to cover the aneurysm neck; 
if that aneurysm was located at an artery branching, we chose 
the branch which enabled us to cover as much of the aneurysm 
neck as possible. This technique often requires catheterisation 
of the M2, A2 branches that start at an unfavourable angle of 
the aneurysm neck. In such cases, a combination of pre-shaped 
(S, J, C) Sl10 microcatheters (Stryker) with a Hybrid 008J micro 
guidewire (Balt) was successfully applied. Due to the unique 
properties of a hybrid stent, a 2-stent Y or T-configuration 
placement was very rarely necessary. 
Those patients who were planned for stent implantation 
received pretreatment with antiplatelet agents. On the day 
before the procedure, the patient was given 600 mg of clopi-
dogrel and 300 mg of aspirin. Patients who underwent stent 
implantation into the cerebral arteries were administered 
75 mg of clopidogrel for three months and 150 mg of aspirin 
daily for six months following stent placement. Follow-up 
head MR angiography was scheduled for 12 months post 
intervention. Residual flow was classified as: A) total oblitera-
tion; B) contrast-filled neck without sac-filling; or C) residual 
aneurysm with sac-filling.
Results
There were 108 patients with a mean age of 61 years 
[57.09 ± 14.27] qualified for embolisation. In one patient with 
an unruptured aneurysm, intervention was abandoned for 
technical reasons (after angiography), meaning that eventu-
ally data from 107 patients was collected and analysed. Half 
of the patients were aged 50–70 and nearly 80% of the whole 
group were female. The indication for intervention in 16 pa-
tients (15%) was subarachnoid haemorrhage in the course of 
aneurysm rupture; in the remaining cases, aneurysms were 
revealed during diagnostic procedures for headaches (most 
commonly) or during imaging examinations unrelated to neu-
rological symptoms. The intracranial segment of the internal 
carotid artery and the anterior communicating artery were the 
most common locations for aneurysms. Nearly one in four of 
the patients revealed another intracranial aneurysm; one in 
10 patients had previously undergone endovascular therapy 
due to an aneurysm in another location. The great majority of 
patients (73%) underwent small aneurysm embolisation (small 
being defined where the largest aneurysm was < 10 mm). 
Clinical and radiological description of the patients who 
underwent embolisation is presented in Table 1.
In 51 patients (53.76%), at least six coils were implanted, 
and stents were placed in 45 patients (42.05%). The most 
common symptoms reported by the patients in the 72 hours 
following intervention were: diffuse headache, vertigo, and 
visual disturbances. Subarachnoid haemorrhage occurred in 
one patient. Ischaemic stroke occurred in two patients. One 
patient with a ruptured ACoA aneurysm died due to acute 
circulatory insufficiency. 
The functional status of nearly 90% of patients on the 
day of discharge from the department (on days 4–21) was 
very good. Those patients who required caregiver assistance 
were previously qualified for embolisation due to a ruptured 
cerebral aneurysm. Table 2 presents the parameters in the 
perioperative period. 
Seventy-eight (72.89%) patients completed a 12-month 
follow-up period. In 11 of those (14.10%), a follow-up MR an-
giography revealed recanalisation after 12 months. The degree 
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F 83 (77.57) 
Arterial hypertension 61 (57)
Diabetes 8 (7.48)
Dyslipidemia 30 (28.03)




























L 39 (50.65)    
Ruptured aneurysm 










Presence of other cerebral aneurysms 24 (22.43)
Previous procedure for (another) cerebral aneurysm 12 (11.21)
F — female; ACoA — anterior communicating artery; MCA — middle cerebral artery; BA — basilar 
artery; ICA — internal carotid artery; ACA — anterior cerebral artery; VA — vertebral artery
Table 2. Parameters related to cerebral aneurysm embolisation in 78 













51 (54.26)      







53 (49.53)    
Complications / clinical status of patients, 1–3 days 
after intervention:
Haematoma at puncture site
Headaches


















Death during hospitalisation 1 (0.93)
ASA — acetylsalicylic acid; CLP — clopidogrel; SAH — subarachnoid haemorrhage; mRS —  modi-
fied Rankin Scale; *based on head MR angiography; **data from 94 procedures
of recanalisation in 10 patients was defined as grade B, and 
in one patient as grade C. This grade C patient required man-
agement during reintervention. For the remaining patients, 
a check-up using MR angiography at six months was recom-
mended. Except for one patient reporting vertigo (probably 
of multifactorial aetiology), the patients requiring a second 
procedure due to aneurysm recanalisation were asymptomatic. 
The only independent risk factor for recanalisation was the 
size of aneurysm > 10 mm (Tab. 3).
The internal carotid artery aneurysm before and after 
embolisation is presented in Figure 2.
Discussion
The most important conclusion that we draw from our 
study is that cerebral aneurysm embolisation is a safe method. 
Recanalisation affects 14% of patients 12 months following the 
intervention. The great majority of patients were asymptomatic 
and did not require urgent management. Instead, radiological 
follow-up was indicated.
Anterior intracranial vascular supply proved to be the most 
common location of aneurysms qualified for endovascular 
therapy. This accords with the findings of epidemiological 
studies related to the location of cerebral aneurysms. In 
our group of patients, diseases causing angiopathy (arterial 
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Table 3. Risk of recanalisation of aneurysm 12 months after embolisation* 
p (factor) RR




*The following co-variables were analysed: age, sex, diabetes, arterial hypertension, dyslipidemia, 
and size of aneurysm ≤ 10 mm or > 10 mm
Figure 2A. Right internal carotid artery aneurysm with a wide neck 
before embolisation                 
Figure 2B. Right internal carotid artery aneurysm with a wide 
neck after embolisation with stent securing the aneurysm neck 
and coils
hypertension, dyslipidemia) were common in 60% and 28%, 
respectively. Women made up the majority of embolised pa-
tients, which is consistent with the gender distribution among 
patients with cerebral aneurysms [2].
The most common symptoms reported by patients 
within the first few days following the intervention were 
headaches with vertigo and atypical visual disturbances. 
Considering the type and transient nature of the complaints, 
these probably resulted from vasoconstriction. Two patients 
suffered ischaemic stroke in the peri-interventional period; 
one had a subarachnoid haemorrhage. Inguinal haematoma 
was found in 5% of patients and this was the most frequent 
extra-neurological complication of the procedure. One 
patient died during hospitalisation due to acute circulatory 
insufficiency. The functional status of the great majority of 
patients on the day of discharge was very good. According 
to the literature, the most common complications after 
embolisation of cerebral aneurysms are haematoma in 
the groin, false aneurysm, and infection. Less frequently 
reported are arterial dissection (0.7%), embolism (2.5%), 
and arterial occlusion (2%) [8]. According to observations 
reported by other authors, the incidence of ischaemic stroke 
in the perioperative period is higher than that of intracra-
nial haemorrhage: 4.81% vs 1.87%, respectively (National 
Inpatient Sample Database) [9]. The mechanism of isch-
aemia in this group of patients may have multiple origins. 
Hypercoagulability status plays a significant role, along with 
the following: inappropriate anticoagulation before and 
during intervention, unstable atherosclerotic plaque, and 
coil extension into the proximal artery [10, 11]. The risk of 
thrombosis increases if the stent does not appose well to the 
vessel wall and/or two stents are used (especially in the Y or 
X configurations). Endothelial damage during the procedure 
may stimulate thrombus formation. Cerebral stroke is more 
likely to occur when managing large aneurysms. The size 
of the thrombus is a risk factor for its propagation and/or 
distal embolisation. The above-mentioned complications are 
reported more often in relation to previously clipped aneu-
rysms than to coiled aneurysms [9, 12]. 
In accordance with the results of meta-analysis of data 
from 7,172 patients, poor functional condition/death is 
observed in 4.7% of patients undergoing embolisation [13]. 
A significantly higher percentage of patients with a good thera-
peutic outcome was found among those treated after 2004 (the 
analysis related to the period 2000 to 2011). A higher risk of 
poor functional status was demonstrated after treatment with 
liquid embolic agents (8.1%; 99% CI: 4.7%, 13.7%) than after 
coil placement (4.9%; 99% CI: 3.8%, 6.3%; p = 0.002) and 
the highest risk was demonstrated after treatment with flow 
diversion (11.5%; 99% CI: 4.9%, 24.6%) [14].
In the BRAT study, embolisation was associated with 
a higher percentage of patients in good functional status 
than in those after microsurgical clip occlusion in a 1.3 and 
6-year observation, particularly in the analysis of the effects of 
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aneurysm treatment in the posterior part of cerebral circula-
tion [14–16]. However, analysis of the results 10 years post 
intervention did not reveal any significant differences in this 
respect [17, 18]. The results clearly proved significantly more 
frequent recanalisation after endovascular therapy: 16.4% vs 
4.6% (p < 0.0001) after a 6-year follow-up [16].
The incidence of recanalisation after embolisation 
of cerebral aneurysms varies between 5% and 34% [19]. 
The risk of recanalisation of an aneurysm depends on the 
parameters related to its morphology (shape/size) and the 
technique applied for the procedure [19, 20]. This risk is 
higher when the aneurysm sac size is > 10 mm and/or neck 
size is > 4 mm [5]. In our study, the size of the aneurysm 
was the only independent risk factor for recanalisation. The 
results of one study showed that an aneurysm sac > 10 mm 
multiplies the risk of recanalisation x 4.5 times [21]. It is 
probable that a larger aneurysm volume makes it more dif-
ficult to stabilise and increase the density of coil placement, 
thus making it easier for coils to slide out of their original 
positions. According to many authors, coil filling density 
of 20-25% protects against recanalisation [6, 8]. In our pre-
sented paper, 5/11 patients after recanalisation had an an-
eurysm sized 10–24 mm; seven of them had at least six coils 
implanted. According to the published data, recanalisation 
is observed in 35% of patients with 11–25 mm aneurysms, 
and in as many as 59% of patients with giant aneurysms 
(> 25 mm) after embolisation [8]. 
One of our patients had a giant aneurysm, and in that case 
recanalisation also occurred.
Evaluation of haemodynamic parameters in the aneu-
rysm sac (i.e. flow velocity and wall shear stress) indicates 
a significantly lower amplitude reduction of the velocity on 
the neck plane in patients undergoing recanalisation [22, 23]. 
The role of inflammation in the recanalisation process is not 
yet established, which is probably important bearing in mind 
other factors in the process of formation, progression and 
rupture of aneurysms [24, 25]. 
According to some authors, the differences in the inci-
dence of recanalisation result from the interval between the 
intervention and follow-up examination. In most study sites, 
it is recommended that patients undergo a follow-up every six 
months (usually involving a head MR angiography). Given the 
low probability of delayed recanalisation, careful monitoring 
is still warranted, although at less frequent intervals (every 
2–3 years) beyond 36 months post embolisation [26]. Some 
observations have suggested that the radiological condition 
reported six months after embolisation remains stable for at 
least two years [27].
According to studies carried out by Canadian authors, 
most recanalised aneurysms are visualised in MR angiography 
within a follow-up period of 12.31 months [28].
Recanalisation is most often asymptomatic. In this case, 
a routine radiological check-up allows for the assessment of 
the long-term effects of the intervention. 
Limitations 
We are aware of the limitations of our study, the most 
significant being its retrospective nature. No doubt the use of 
DSA angiography to assess the degree of recanalisation would 
be a more valuable procedure. However, due to the invasiveness 
of the examination and its limited availability, we decided to 
adopt head MR angiography instead.
Conclusions
Embolisation of cerebral aneurysms is a safe method with 
few perioperative complications, most of them being mild 
and transient.
The size of the aneurysm during qualification for em-
bolisation is a risk factor for recanalisation in the subsequent 
12 months. 
Recanalisation of embolised cerebral aneurysms afflicts 
fewer than one in five patients in a 12-month follow-up, and 
is most often asymptomatic. 
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